Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jul 29, 2010
-
Jun 26, 2010- Study Findings Presented at American Diabetes Association's 70th Annual Scientific Sessions -
-
Jun 25, 2010- Study Results Presented at American Diabetes Association's 70th Annual Scientific Sessions -
-
Jun 17, 2010- First and only therapy to provide significant survival benefit in second-line metastatic hormone-refractory prostate cancer -
-
May 26, 2010- Alliance formed to advance cutting-edge research and foster collaboration between academia and industry -
-
May 5, 2010- Sanofi-aventis Supports Consortium's Activities to Fund Promising Early-Stage Life Sciences Companies -
-
Apr 29, 2010
-
Apr 12, 2010The licensed technology was developed by the NMRC with the help of the University of Colorado
-
Apr 1, 2010Interactive Exhibit Unveiled at New Jersey's Liberty Science Center as it Embarks on Three-Year, 12-City Tour
-
Mar 11, 2010Chattem Becomes the U.S. Consumer Healthcare Platform for sanofi-aventis
-
Mar 3, 2010- Results observed in patients treated with cabazitaxel plus prednisone whose disease progressed despite prior docetaxel-based chemotherapy -
-
Mar 3, 2010The Coalition to Prevent DVT Sends Awareness into Motion with an Educational Program Focusing on Preventative Care Through Movement
-
Feb 23, 2010New Data Published by Journal of American Academy of Dermatology Demonstrated Sustained Efficacy Up to 25 Months
-
Jan 20, 2010"AFib Support Team" Offers Insights on Comprehensive Approach to Management of Serious Heart Condition
-
Dec 21, 2009Fluzone® High-Dose (Influenza Virus Vaccine) strengthens immune response in the 65+ population, an age group that suffers disproportionately from influenza and its complications
-
Dec 21, 2009-- Combination Strengthens sanofi-aventis' Strategy to Accelerate Growth Through Innovation, Geographic Expansion and External Growth
-
Dec 15, 2009Novel vaccine approach tested against one of the most common causes of hospital-acquired infection in Europe and North America
-
Dec 11, 2009- Atul Dhir, M.D., Ph.D. has been appointed new BiPar CEO to continue growing entrepreneurial and innovative culture -
-
Nov 11, 2009Final data confirm immunogenicity, safety profile
-
Nov 2, 2009The two-dose meningococcal quadrivalent conjugate vaccine was generally well-tolerated
-
Oct 16, 2009- Elitek is now approved to manage a potentially life-threatening complication associated with anti-cancer treatment in adults -
-
Oct 14, 2009The first clinical trial data from America’s youngest vaccine recipients, children 6 months through 9 years of age, show the vaccine induces an immune response and is well-tolerated
-
Oct 6, 2009Taking Control of Your Diabetes (TCOYD) Calls on Marketing Leaders and Creative Minds to "Start Taking Action Now for Diabetes"
-
Oct 1, 2009Data from studies in adults 18 years of age and older provide confirmation that one dose of vaccine produces a robust immune response even in those over the age of 65 years
-
Oct 1, 2009Women may delay treatment or seek injectable procedures
-
Sep 21, 2009Company has now committed to produce 75.3 million doses of vaccine for the U.S. government
-
Sep 16, 2009"AF Stat(TM) Call to Action for Atrial Fibrillation" Report Cites Limited Understanding, Disconnected Dialogue and Uncoordinated Care as Key Barriers to Improved Outcomes
-
Sep 15, 2009Influenza A (H1N1) 2009 Monovalent Vaccine licensure a key U.S. milestone in preparing for pandemic response this Fall
-
Aug 24, 2009Approval Includes Use in Patients Two Years and Older with Seasonal Nasal Allergies Which Affect Forty Percent of Children in the U.S.
-
Aug 20, 2009New York City Proclaims August 20, 2009 “Pertussis Awareness Day”
-
Aug 17, 2009- Prophylaxis with Lovenox® (enoxaparin sodium injection) offered a cost reduction per discharge -
-
Aug 7, 2009Company responds to FDA recommendation for influenza virus strain change supplement
-
Jul 29, 2009
-
Jul 27, 2009Early shipment of vaccine to assist public health in immunization planning
-
Jul 15, 2009Leading international experts conclude that these analyses present inconclusive and conflicting data
-
Jul 2, 2009Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - - U.S. commercial launch planned for the summer of 2009
-
Jun 25, 2009The CDC Reinstates Booster Dose of Hib Vaccine
-
Jun 17, 2009Christopher A. Viehbacher Reaffirmed Sanofi-aventis’ Commitment to Access to Health during the Pacific Health Summit in Seattle
-
Jun 6, 2009A1C and FBG Results for Patients 65 and Under Treated with Lantus and NPH were Similar
-
Jun 6, 2009Study Presented at 69th Annual ADA Scientific Sessions Examined Efficacy and Safety of Basal-Prandial Treatment with Lantus(R) and Apidra(R)
-
May 27, 2009Company to take first steps toward large-scale production
-
May 25, 2009Initial U.S. order for bulk vaccine valued at $190 million
-
May 6, 2009Sanofi Pasteur committed to increasing its seasonal and pandemic influenza preparedness
-
Apr 29, 2009Sanofi-aventis and its vaccines division Sanofi Pasteur pursue pandemic preparedness plan in response to WHO Phase 4 influenza pandemic alert
-
Apr 22, 2009Singer, actress and mother teams up with the March of Dimes and sanofi pasteur to launch national whooping cough education campaign
-
Apr 22, 2009Swiftwater site project hailed for environmental protection and responsible economic development benefits
-
Apr 21, 2009Web Site Teams Up with AnnaLynne McCord and Dr. Jeanine Downie to Provide Skin Care Tips and Expert Advice to Look and Feel Your Best by Prom Night
-
Apr 21, 2009Ben Vereen to Extend National Diabetes Awareness Campaign in Six Additional Cities
-
Apr 21, 2009Interdisciplinary team of experts joins forces to discuss the latest tools to combat this preventable but deadly disease
-
Mar 6, 2009Development and Commercialization for Cetrorelix Pamoate in Benign Prostatic Hyperplasia
-
Feb 26, 2009Apidra(R) SoloSTAR(R) is a Convenient Insulin Delivery Device to Help Patients with Diabetes Improve Glycemic Control
-
Feb 11, 2009Multaq(R) (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation
-
Feb 5, 2009Team Type 1 Expands Its Roster, Fielding Five Teams to Spread Personal Messages of Successful Diabetes Management to People Living with Type 1 and Type 2 Diabetes
-
Feb 3, 2009"KidCare Kit" offers quick-reference materials and multimedia tools to guide families through the first 30 days following a child's diagnosis
-
Jan 29, 2009Sanofi-aventis U.S. Establishes 'Diabetes National Alliance' of Healthcare Professionals to Help Meet Needs of Growing Diabetes Epidemic in U.S.
-
Jan 22, 2009The Sanofi-Aventis U.S. Community Health Partnership - It's In Our Hands - Has Been Designed To Help Improve Patient Care By Connecting Patients And Caregivers To Healthcare Resources And Services In Local Communities
-
Dec 11, 2008The Sanofi-Aventis U.S. Community Health Partnership - It’s In Our Hands - Has Been Designed To Help Improve Patient Care By Connecting Patients And Caregivers To Healthcare Resources And Services In Local Communities
-
Nov 11, 2008New post-hoc analysis from Athena Study showed that Multaq® on top of standard therapy significantly decreased the total number of hospital days by 28% in patients with atrial fibrillation or flutter
-
Oct 31, 2008
-
Oct 23, 2008Sanofi-aventis will comply with the European Authorities request to temporarily suspend the marketing authorisation of Acomplia® in obese and overweight patients and will make every effort to actively support patients and Health Care Professionals.
-
Oct 16, 2008Champions Hope to Inspire People Living with Uncontrolled Blood Sugar Levels to Join the Circle and Pledge to Get Serious About Managing Their Diabetes
-
Oct 9, 20082008 Olympic Champion Shawn Johnson Uses Participation in National TV Show to Urge Women to Get the Facts, Share the Feelings, and Look to the Future
-
Sep 30, 2008Shawn Johnson and Shannon Miller Featured at Educational Event for the Community
-
Sep 26, 2008A First for Central New Jersey: One-of-A-Kind Shop Caters to Cancer Patients’ Unique Needs
-
Sep 24, 2008Ben Vereen Issues a Call-to-Action for People with Diabetes to Join Him to Take the Stage and Act on Their Diabetes Today